| Date | Title | Description |
| 07.04.2026 | Change of date for the Annual General Meeting in SyntheticMR AB (publ) | Change of date for the Annual General Meeting in SyntheticMR AB (publ)
Tue, Apr 07, 2026 15:46 CET Report this content
SyntheticMR AB (publ) has previously announced that the Annual General Meeting 2026 would be held on Tuesday, May 12, 202... |
| 11.02.2026 | SyntheticMR’s rights issue has been registered – conversion of BTA into shares | SyntheticMR’s rights issue has been registered – conversion of BTA into shares
Wed, Feb 11, 2026 16:51 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA... |
| 06.02.2026 | Year-End report January – December 2025 | Year-End report January – December 2025
Fri, Feb 06, 2026 08:30 CET Report this content
Fourth quarter in brief
Net sales amounted to 18.0 million SEK (12.6), which means an increase in sales of 42 percent.
Operating profit amounted to -5.3... |
| 04.02.2026 | SyntheticMR publishes the outcome of the rights issue | SyntheticMR publishes the outcome of the rights issue
Wed, Feb 04, 2026 15:16 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, JAPAN, CANAD... |
| 22.01.2026 | SyntheticMR Secures Capital for Global AI Neurodiagnostics Expansion Amidst Strong Q4 Revenue Surge | SyntheticMR AB launches a SEK 32.8 million rights issue. Shareholders approved the capital raise. This funding fuels strategic growth. Preliminary Q4 2025 financials reveal a 43% revenue surge. The company leverages its Combinostics acquisi... |
| 20.01.2026 | Today the subscription period commences in SyntheticMR AB’s rights issue | Today the subscription period commences in SyntheticMR AB’s rights issue
Tue, Jan 20, 2026 07:19 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, C... |
| 19.01.2026 | SyntheticMR AB publishes financial guidance ahead of the forthcoming rights issue | SyntheticMR AB publishes financial guidance ahead of the forthcoming rights issue
Mon, Jan 19, 2026 08:48 CET Report this content
SyntheticMR AB (publ) (“SyntheticMR” or the “Company”) publishes financial guidance based on preliminary figur... |
| 19.01.2026 | SyntheticMR AB publishes information document regarding the rights issue | SyntheticMR AB publishes information document regarding the rights issue
Mon, Jan 19, 2026 13:51 CET Report this content
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, C... |
| 16.01.2026 | Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR’s Position with a Broader Neuroimaging Offering | Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR’s Position with a Broader Neuroimaging Offering
Fri, Jan 16, 2026 09:15 CET Report this content
SyntheticMR AB (publ), a global leader in quantitative MRI software, today annou... |
| 15.01.2026 | SyntheticMR AB announces intention to publish financial guidance ahead of upcoming rights issue | SyntheticMR AB announces intention to publish financial guidance ahead of upcoming rights issue
Thu, Jan 15, 2026 08:46 CET Report this content
SyntheticMR AB (publ) (“SyntheticMR”) hereby announces that the company intends to publish finan... |
| 09.01.2026 | Report from the extraordinary general meeting in SyntheticMR AB (publ) | Report from the extraordinary general meeting in SyntheticMR AB (publ)
Fri, Jan 09, 2026 12:08 CET Report this content
Today, the 9th of January 2026, an extraordinary general meeting was held in SyntheticMR AB (publ). Below is a summary of... |
| 18.12.2025 | Notice of extra general meeting in SyntheticMR AB (publ) | Notice of extra general meeting in SyntheticMR AB (publ)
Thu, Dec 18, 2025 09:01 CET Report this content
The shareholders of SyntheticMR AB (publ), reg. no. 556723-8877, (the "Company") are hereby invited to the extra general meet... |
| 28.11.2025 | Interim report July – September 2025 | Interim report July – September 2025
Fri, Nov 28, 2025 08:00 CET Report this content
Third quarter in brief
Net sales amounted to 12.4 million SEK (13.3), which means a decrease in sales of 7 percent.
Operating profit amounted to -25.1 mill... |
| 25.11.2025 | SyntheticMR AB (publ) postpones the interim report for the third quarter of 2025 | SyntheticMR AB (publ) postpones the interim report for the third quarter of 2025
Tue, Nov 25, 2025 19:07 CET Report this content
The Board of Directors of SyntheticMR AB (publ) has decided to postpone the publication of the interim report f... |
| 22.11.2025 | Marcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ) | Marcel Warntjes resigns from the Board of Directors of SyntheticMR AB (publ)
Sat, Nov 22, 2025 15:53 CET Report this content
22 November 2025
SyntheticMR AB (publ) announces today that Marcel Warntjes, at his own request, has decided to res... |
| 29.10.2025 | Nomination Committee appointed for the 2026 Annual General Meeting in SyntheticMR | Nomination Committee appointed for the 2026 Annual General Meeting in SyntheticMR
Wed, Oct 29, 2025 08:50 CET Report this content
The following shareholders have been identified as the three largest shareholders as of 2025-09-30 who are wil... |
| 01.09.2025 | Lena Åredal Assumes Role as CEO of SyntheticMR AB (publ) | Lena Åredal Assumes Role as CEO of SyntheticMR AB (publ)
Mon, Sep 01, 2025 08:18 CET Report this content
On June 13, the Board of Directors of SyntheticMR announced the appointment of Lena Åredal as the company’s new Chief Executive Officer... |
| 26.08.2025 | Interim report April– June 2025 | Interim report April– June 2025
Tue, Aug 26, 2025 08:07 CET Report this content
Second quarter in brief
Net sales amounted to 12.4 million SEK (11.9), which means an increase in sales of 4 percent.
Operating profit amounted to -8.6 million ... |
| 13.06.2025 | Lena Åredal Appointed New CEO of SyntheticMR AB (publ) | Lena Åredal Appointed New CEO of SyntheticMR AB (publ)
Fri, Jun 13, 2025 08:56 CET Report this content
June 13, 2025
The Board of Directors of SyntheticMR AB (publ) has appointed Lena Åredal as the company’s new Chief Executive Officer. She... |
| 03.06.2025 | New Multicenter Study Demonstrates SyMRI’s Potential to Transform Clinical Neuroimaging Workflows | New Multicenter Study Demonstrates SyMRI’s Potential to Transform Clinical Neuroimaging Workflows
Tue, Jun 03, 2025 10:30 CET Report this content
SyntheticMR AB (publ) is proud to share the results of a newly published multicenter clinical ... |
| 22.05.2025 | SyntheticMR's Bumpy Road: Navigating Challenges and Opportunities in 2025 | SyntheticMR AB, a player in the medical imaging field, has faced a tumultuous start to 2025. The interim report for the first quarter reveals a company grappling with declining sales, leadership changes, and strategic acquisitions. Yet, ami... |
| 20.05.2025 | Interim report January – March 2025 | Interim report January – March 2025
Tue, May 20, 2025 08:18 CET Report this content
First quarter in brief
Net sales amounted to 14.2 million SEK (17.8), which means a decrease in sales of 20 percent.
Operating profit amounted to -10.2 mill... |
| 20.05.2025 | Report from Annual General Meeting in SyntheticMR AB (publ) | Report from Annual General Meeting in SyntheticMR AB (publ)
Tue, May 20, 2025 18:59 CET Report this content
The Annual General Meeting (AGM) of SyntheticMR AB (publ) was held on May 20, 2025, whereby the meeting resolved in accordance with ... |
| 22.04.2025 | Notice to attend the annual general meeting of SyntheticMR AB (publ) | Notice to attend the annual general meeting of SyntheticMR AB (publ)
Tue, Apr 22, 2025 08:48 CET Report this content
The shareholders of SyntheticMR AB (publ), corporate Reg. No. 556723-8877, are hereby invited to attend the annual general ... |
| 16.04.2025 | SyntheticMR publishes annual report for 2024 | SyntheticMR publishes annual report for 2024
Wed, Apr 16, 2025 08:42 CET Report this content
SyntheticMR AB (publ) hereby announces that the Group´s annual report for 2024 has been published.
The annual report is also available on Synthetic... |
| 25.02.2025 | Year-End report January – December 2024 | Year-End report January – December 2024
Tue, Feb 25, 2025 08:43 CET Report this content
Fourth quarter in brief
Net sales amounted to 12.6 million SEK (30.1), which means a decrease in sales of 58 percent.
Operating profit amounted to -7,5 ... |
| 30.01.2025 | SyntheticMR Receives Regulatory Clearance of SyMRI 3D in Japan | SyntheticMR Receives Regulatory Clearance of SyMRI 3D in Japan
Thu, Jan 30, 2025 13:05 CET Report this content
SyntheticMR, global leader in quantitative imaging software, is pleased to announce that its cutting-edge SyMRI 15 (3D) solution ... |
| 23.01.2025 | Leadership Changes at SyntheticMR: A New Chapter Begins | In the world of business, change is the only constant. At SyntheticMR AB, a company known for its innovative software solutions in Magnetic Resonance Imaging (MRI), the winds of change are blowing strong. Recent leadership shifts have set t... |
| 21.01.2025 | SyntheticMR AB (publ) appoints CFO Johanna Norén as Acting CEO | SyntheticMR AB (publ) appoints CFO Johanna Norén as Acting CEO
Tue, Jan 21, 2025 20:28 CET Report this content
January 21, 2025
Vedran Beglerbegovic has today informed the Board of Directors that he is resigning from the position as CEO of ... |
| 17.01.2025 | Vedran Beglerbegovic appointed as new CEO of SyntheticMR AB (publ) | Vedran Beglerbegovic appointed as new CEO of SyntheticMR AB (publ)
Fri, Jan 17, 2025 18:30 CET Report this content
January 17, 2025
Ulrik Harrysson has today informed the Board of Directors of his resignation as CEO with immediate effect.
T... |
| 16.01.2025 | SyntheticMR announces final outcome in the oversubscribed rights issue | SyntheticMR announces final outcome in the oversubscribed rights issue
Thu, Jan 16, 2025 08:14 CET Report this content
16 january 2025
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO A... |
| 14.01.2025 | SyntheticMR’s rights issue oversubscribed – preliminary outcome is announced | SyntheticMR’s rights issue oversubscribed – preliminary outcome is announced
Tue, Jan 14, 2025 13:58 CET Report this content
14 January 2025
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR ... |
| 02.01.2025 | SyntheticMR completes the acquisition of Combinostics Oy | SyntheticMR completes the acquisition of Combinostics Oy
Thu, Jan 02, 2025 18:57 CET Report this content
SyntheticMR AB ("SyntheticMR" or the "Company") has today, the 2nd of January 2025, acquired all shares in Finnish ... |
| 20.12.2024 | SyntheticMR publishes disclosure document regarding rights issue | SyntheticMR publishes disclosure document regarding rights issue
Fri, Dec 20, 2024 08:33 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG KONG, J... |
| 17.12.2024 | Announcement from extra general meeting in SyntheticMR AB (publ) | Announcement from extra general meeting in SyntheticMR AB (publ)
Tue, Dec 17, 2024 14:51 CET Report this content
The extra general meeting of SyntheticMR AB (publ) ("SyntheticMR" or the "Company") was held today on 17 De... |
| 06.12.2024 | SyntheticMR receives FDA 510(k) clearance for SyMRI 15 | SyntheticMR receives FDA 510(k) clearance for SyMRI 15
Fri, Dec 06, 2024 20:44 CET Report this content
SyntheticMR, leader in quantitative imaging software, is pleased to announce that its SyMRI 15 solution has obtained 510(k) clearance fro... |
| 04.12.2024 | SyntheticMR AB (publ) appoints Vedran Beglerbegovic as Acting CEO for SyntheticMR | SyntheticMR AB (publ) appoints Vedran Beglerbegovic as Acting CEO for SyntheticMR
Wed, Dec 04, 2024 16:23 CET Report this content
The board of SyntheticMR AB (publ) has today decided to appoint Vedran Beglerbegovic as Acting CEO with immedi... |
| 28.11.2024 | SyntheticMR resolves on a rights issue of approximately SEK 65 million | SyntheticMR resolves on a rights issue of approximately SEK 65 million
Thu, Nov 28, 2024 23:05 CET Report this content
THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, HONG K... |
| 24.11.2024 | SyntheticMR Faces Challenges Amidst Strategic Changes and Regulatory Approvals | SyntheticMR AB, a pioneer in Magnetic Resonance Imaging (MRI) software, is navigating turbulent waters. The company recently appointed a Nomination Committee for its 2025 Annual General Meeting, signaling a commitment to governance and shar... |
| 22.11.2024 | Nomination Committee appointed for the 2025 Annual General Meeting in SyntheticMR | Nomination Committee appointed for the 2025 Annual General Meeting in SyntheticMR
Fri, Nov 22, 2024 15:00 CET Report this content
The following shareholders have been identified as the three largest shareholders as of 2024-09-30 who are wil... |
| 18.11.2024 | Interim report July – September 2024 | Interim report July – September 2024
Mon, Nov 18, 2024 08:14 CET Report this content
Third quarter in brief
Net sales amounted to 13.3 million SEK (21.7), which means a decrease in sales of 39 percent.
Operating profit amounted to -5.3 mill... |
| 06.11.2024 | SyntheticMR AB (publ) brings forward the publication date of the interim report for the period 1 January – 30 September 2024 to Monday, 18 November 2024. | SyntheticMR AB (publ) brings forward the publication date of the interim report for the period 1 January – 30 September 2024 to Monday, 18 November 2024.
Wed, Nov 06, 2024 18:52 CET Report this content
The previously announced publication d... |
| 29.10.2024 | SyntheticMR Receives Regulatory Approval for SyMRI 15 in Australia | SyntheticMR Receives Regulatory Approval for SyMRI 15 in Australia
Tue, Oct 29, 2024 11:27 CET Report this content
SyntheticMR, global leader in advanced quantitative imaging solutions, is thrilled to announce that its SyMRI 15 solution has... |
| 02.10.2024 | SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland | SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland
Wed, Oct 02, 2024 10:15 CET Report this content
SyntheticMR AB, global leader in advanced quantitative imaging software, is pleased to announce that its SyMRI 15 solution ... |
| 25.09.2024 | SyntheticMR Announces Regulatory Clearance for SyMRI 15 in the UK | SyntheticMR Announces Regulatory Clearance for SyMRI 15 in the UK
Wed, Sep 25, 2024 10:00 CET Report this content
SyntheticMR, leader in quantitative imaging software, is pleased to announce that its SyMRI 15 solution has received regulator... |
| 04.09.2024 | SyntheticMR Announces the Appointment of Francois Hebert as New President, North America | SyntheticMR Announces the Appointment of Francois Hebert as New President, North America
Wed, Sep 04, 2024 10:00 CET Report this content
SyntheticMR is thrilled to announce the appointment of Francois Hebert as the new President of Syntheti... |
| 27.08.2024 | Interim report April – June 2024 | Interim report April – June 2024
Tue, Aug 27, 2024 08:49 CET Report this content
Second quarter in brief
Net sales amounted to 11.9 million SEK (21.2), which means a decrease in sales of 44 percent.
Operating profit amounted to -8.2 million... |
| 19.08.2024 | SyntheticMR Receives Regulatory Approval for SyMRI in Taiwan | SyntheticMR Receives Regulatory Approval for SyMRI in Taiwan
Mon, Aug 19, 2024 10:48 CET Report this content
SyntheticMR announced today that its quantitative imaging software solution, SyMRI 12, has received regulatory approval from the Ta... |
| 09.07.2024 | SyntheticMR announces estimated net sales of SEK 12m. (21.2) for quarter 2 of 2024 depending on organizational changes in USA. The net sales target for 2024 is therefore not expected to be achieved | SyntheticMR announces estimated net sales of SEK 12m. (21.2) for quarter 2 of 2024 depending on organizational changes in USA. The net sales target for 2024 is therefore not expected to be achieved
Tue, Jul 09, 2024 21:34 CET Report this co... |
| 26.06.2024 | SyMRI 15 by SyntheticMR obtains CE-Marking | SyMRI 15 by SyntheticMR obtains CE-Marking
Wed, Jun 26, 2024 13:30 CET Report this content
SyntheticMR announced today that version 15 of their next-generation imaging solution, SyMRI Neuro, has obtained CE-marking.
SyMRI 15 is a cutting-ed... |
| 22.05.2024 | Report from Annual General Meeting in SyntheticMR AB (publ) | Report from Annual General Meeting in SyntheticMR AB (publ)
Wed, May 22, 2024 08:22 CET Report this content
The Annual General Meeting (AGM) of SyntheticMR AB (publ) was held on May 21, 2024, whereby the meeting resolved in accordance with ... |
| 21.05.2024 | Interim report January – March 2024 | Interim report January – March 2024
Tue, May 21, 2024 08:08 CET Report this content
First quarter in brief
Net sales amounted to 17.8 million SEK (16.1), which means a sales growth of 10 percent.
Operating profit amounted to 2.7 million SEK... |
| 19.04.2024 | SyntheticMR publishes annual report for 2023 | SyntheticMR publishes annual report for 2023
Fri, Apr 19, 2024 07:31 CET Report this content
SyntheticMR AB (publ) hereby announces that the Group´s annual report for 2023 has been published.
The annual report is also available on Synthetic... |
| 19.04.2024 | Notice to attend the annual general meeting of SyntheticMR AB (publ) | Notice to attend the annual general meeting of SyntheticMR AB (publ)
Fri, Apr 19, 2024 08:01 CET Report this content
The shareholders of SyntheticMR AB (publ), corporate Reg. No. 556723-8877, are hereby invited to attend the annual general ... |
| 17.04.2024 | SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR’s SyMRI NEURO Software at SimonMed Facilities. | SyntheticMR and SimonMed Expand Trials of Synthetic MRI Testing and Announce Upcoming Expansion of Synthetic Availability from SyntheticMR’s SyMRI NEURO Software at SimonMed Facilities.
Wed, Apr 17, 2024 10:15 CET Report this content
SimonM... |
| 27.03.2024 | SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D | SyntheticMR receives FDA 510(k) clearance for their next Generation Solution SyMRI 3D
Wed, Mar 27, 2024 11:01 CET Report this content
SyntheticMR announced today that their next-generation imaging solution with isotropic resolution, SyMRI 3... |
| 16.03.2024 | Rimes Launches AI-powered Data Lakehouse Copilot for Natural Language Insights | Rimes is pleased to announce the launch of its Data Lakehouse Copilot. The Large Language Model (LLM) powered by the AI Copilot quickly provides unique insights from data using natural language. The initial focus for the AI Copilot is to su... |
| 13.03.2024 | HKUST Introduces Asia’s First “AI Lecturers” in Class to Promote Teaching Innovation | A New Initiative to Foster Cross-Campus Study in HK and Guangzhou
Following the birth of “AI singers” and “AI weather presenters”, adding to the ever-expanding AI (Artificial Intelligence) family is the inaugural cohort of “AI Lecturers” cr... |
| 13.03.2024 | First Advantage Introduces RightID to Detect Job Applicant Fraud in Pre-Hire Process | Multi-Layered Approach Designed to Flag Inconsistencies and Deep-Fake Efforts Delivers a Consistent, Secure Solution to Growing Problem
First Advantage Corporation, a leading provider of employment background screening, identity, and verifi... |
| 12.03.2024 | Decided allocation regarding incentive program LTIP 2024 and TO 2 | Decided allocation regarding incentive program LTIP 2024 and TO 2
Tue, Mar 12, 2024 18:12 CET Report this content
At the extraordinary general meeting on February 20, 2024, it was decided to introduce the incentive program LTIP 2024 for per... |
| 12.03.2024 | Philips and SyntheticMR Collaboration Advances AI in MRI Diagnostic Imaging: GlobalData | Philips recently announced a collaboration with SyntheticMR to develop quantitative brain imaging tools powered by artificial intelligence (AI) to diagnose disorders such as multiple sclerosis (MS), traumatic brain injury, and dementia. Wit... |
| 05.03.2024 | Fixed subscription price for warrants of series TO 2 and TO 3 | Fixed subscription price for warrants of series TO 2 and TO 3
Tue, Mar 05, 2024 21:54 CET Report this content
At the extraordinary general meeting on February 20, 2024, it was decided to introduce the incentive program LTIP 2024 for personn... |
| 01.03.2024 | Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients | Philips teams with SyntheticMR to deliver breakthrough AI-based quantitative brain imaging in MR to advance neurology care for patients
Fri, Mar 01, 2024 09:00 CET Report this content
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in... |
| 20.02.2024 | Year-End report January – December 2023 | Year-End report January – December 2023
Tue, Feb 20, 2024 08:09 CET Report this content
Fourth quarter in brief
Net sales amounted to 30.1 million SEK (20.6), which means a sales growth of 46 percent.
Operating profit amounted to 8.8 millio... |
| 20.02.2024 | Report from the extraordinary general meeting in SyntheticMR AB (publ) | Report from the extraordinary general meeting in SyntheticMR AB (publ)
Tue, Feb 20, 2024 16:18 CET Report this content
Today, the 20th of February 2024, an extraordinary general meeting was held in SyntheticMR AB (publ). Below is a summary ... |
| 19.01.2024 | Notice to attend the extraordinary general meeting of SyntheticMR AB (publ) | Notice to attend the extraordinary general meeting of SyntheticMR AB (publ)
Fri, Jan 19, 2024 13:50 CET Report this content
Shareholders in SyntheticMR AB (publ), corporate Reg. NO. 556723-8877, are hereby invited to attend an extraordinary... |
| 18.12.2023 | SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking | SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking
Mon, Dec 18, 2023 10:00 CET Report this content
SyntheticMR announced today that their next-generation imaging solution with isotropic 3D resolution, SyM... |
| 13.12.2023 | SYNTHETICMR RECEIVES SIGNIFICANT ORDER FROM OEM PARTNER | SYNTHETICMR RECEIVES SIGNIFICANT ORDER FROM OEM PARTNER
Wed, Dec 13, 2023 08:54 CET Report this content
SyntheticMR announced today that they have received an order from an OEM partner.
The order is for licenses of SyntheticMR’s product pac... |
| 30.11.2023 | SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D | LINKÖPING, Sweden, Nov. 30, 2023 /PRNewswire/ -- SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D.
The expanded agreement between Philips and SyntheticMR means that SyMRI 3D will be incl... |
| 30.11.2023 | SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D | SyntheticMR and Philips Announce Expanded Global Partnership for SyMRI 3D
Thu, Nov 30, 2023 09:43 CET Report this content
SyntheticMR announced today that they have expanded their partnership with Philips to include SyMRI 3D.
The expanded a... |
| 22.11.2023 | SyntheticMR Has Submitted Their Next Generation Solution, SyMRI 3D for 510(k) Clearance | SyntheticMR Has Submitted Their Next Generation Solution, SyMRI 3D for 510(k) Clearance
Wed, Nov 22, 2023 08:48 CET Report this content
SyntheticMR announced today that their next-generation imaging solution with isotropic resolution, SyMRI... |
| 10.11.2023 | Interim report July – September 2023 | Interim report July – September 2023
Fri, Nov 10, 2023 08:11 CET Report this content
Third quarter in brief
Net sales amounted to 21.7 million SEK (19.0), which means a sales growth of 14 percent.
Operating profit amounted to 4.5 million SE... |
| 22.08.2023 | Interim report April – June 2023 | Interim report April – June 2023
Tue, Aug 22, 2023 08:05 CET Report this content
Second quarter in brief
Net sales amounted to 21.2 million SEK (18.7), which means a sales growth of 13 percent.
Operating profit amounted to 2.8 million SEK (... |
| 13.06.2023 | SyntheticMR Introduces Quantitative Neuro Reports to Enhance Clinical Workflow | SyntheticMR Introduces Quantitative Neuro Reports to Enhance Clinical Workflow
Tue, Jun 13, 2023 10:00 CET Report this content
SyntheticMR has released a new update to SyMRI 11.3.11 & 12.1.11 that provides condensed and relevant quantit... |
| 31.05.2023 | SyntheticMR Receives Regulatory Approval for their Innovative SyMRI Software Solution in South Korea | SyntheticMR Receives Regulatory Approval for their Innovative SyMRI Software Solution in South Korea
Wed, May 31, 2023 10:00 CET Report this content
SyntheticMR announced today that their quantitative imaging software solution SyMRI 12.1 ha... |
| 24.05.2023 | Report from Annual General Meeting in SyntheticMR AB (publ) | Report from Annual General Meeting in SyntheticMR AB (publ)
Wed, May 24, 2023 08:32 CET Report this content
The Annual General Meeting (AGM) of SyntheticMR AB (publ) was held on May 23, 2023, whereby the meeting resolved in accordance with ... |
| 23.05.2023 | Interim report January – March 2023 | Interim report January – March 2023
Tue, May 23, 2023 08:08 CET Report this content
First quarter in brief
Net sales amounted to 16,1 million SEK (9,9), which means a sales growth of 63 percent.
Operating profit amounted to -2 million SEK (... |
| 14.04.2023 | Notice to attend the annual general meeting of SyntheticMR AB (publ) | Notice to attend the annual general meeting of SyntheticMR AB (publ)
Fri, Apr 14, 2023 07:22 CET Report this content
The shareholders of SyntheticMR AB (publ), corporate Reg. No. 556723-8877, are hereby invited to attend the annual general ... |
| 11.04.2023 | SyntheticMR publishes annual report for 2022 | SyntheticMR publishes annual report for 2022
Tue, Apr 11, 2023 08:40 CET Report this content
SyntheticMR AB (publ) hereby announces that the Group´s annual report for 2022 has been published.
The annual report is also available on Synthetic... |
| 24.03.2023 | SyntheticMR’s Innovative SyMRI Software Receives Regulatory Approval in Singapore | SyntheticMR’s Innovative SyMRI Software Receives Regulatory Approval in Singapore
Fri, Mar 24, 2023 11:21 CET Report this content
SyntheticMR announced today that their quantitative imaging software solution SyMRI 12.1 has received regulato... |
| 02.03.2023 | SyntheticMR’s Receives Regulatory Clearance for SyMRI in the UK | SyntheticMR’s Receives Regulatory Clearance for SyMRI in the UK
Thu, Mar 02, 2023 10:02 CET Report this content
SyntheticMR announced today that their quantitative imaging software solution SyMRI has received regulatory clearance in the UK.... |
| 27.02.2023 | SyntheticMR’s Innovative Software Receives Regulatory Approval in Canada | SyntheticMR’s Innovative Software Receives Regulatory Approval in Canada
Mon, Feb 27, 2023 10:12 CET Report this content
SyntheticMR announced today that their quantitative imaging software solution SyMRI has received regulatory approval in... |
| 15.02.2023 | Update regarding call options issued by the main owners to senior executives | Update regarding call options issued by the main owners to senior executives
Wed, Feb 15, 2023 18:02 CET Report this content
On August 27, 2021, SyntheticMR AB (publ) ("SyntheticMR") announced that the company's principal sharehol... |
| 15.02.2023 | Year-End report January – December 2022 | Year-End report January – December 2022
Wed, Feb 15, 2023 08:09 CET Report this content
Fourth quarter in brief
Net sales amounted to 20,6 million SEK (18,4), which means a sales growth of 12 percent.
Operating profit amounted to 2,1 millio... |
| 08.12.2022 | SyntheticMR signs sales agreement regarding SyMRI NEURO | SyntheticMR signs sales agreement regarding SyMRI NEURO
Thu, Dec 08, 2022 13:02 CET Report this content
SyntheticMR announces today that they have reached an agreement with one of their partners, which is a world-leading manufacturer of MRI... |
| 17.11.2022 | Nomination Committee appointed for the 2023 Annual General Meeting in SyntheticMR | Nomination Committee appointed for the 2023 Annual General Meeting in SyntheticMR
Thu, Nov 17, 2022 15:43 CET Report this content
The following shareholders have been identified as the three largest shareholders as of 2022-09-30 who are wil... |
| 16.11.2022 | Interim report July – September 2022 | Interim report July – September 2022
Wed, Nov 16, 2022 07:46 CET Report this content
Third quarter in brief
Net sales amounted to 19.0 million SEK (13.6), which means a sales growth of 40 percent.
Operating profit amounted to 4.4 million SE... |
| 28.10.2022 | SyntheticMR receives their EU Medical Device Regulation (MDR) certificate | SyntheticMR receives their EU Medical Device Regulation (MDR) certificate
Fri, Oct 28, 2022 12:01 CET Report this content
SyntheticMR announced today that they have received their EU Medical Device Regulation (MDR) certificate. This is a ne... |
| 06.09.2022 | SyntheticMR’s Innovative SyMRI Software Receives Regulatory Approval in Malaysia | SyntheticMR’s Innovative SyMRI Software Receives Regulatory Approval in Malaysia
Tue, Sep 06, 2022 09:00 CET Report this content
SyntheticMR announced today that their quantitative imaging software solution SyMRI has received regulatory app... |
| 29.08.2022 | SyntheticMR expands with a new subsidiary in Japan | SyntheticMR expands with a new subsidiary in Japan
Mon, Aug 29, 2022 11:04 CET Report this content
SyntheticMR announced today that they are expanding with a new subsidiary in Japan. The subsidiary will be led by Yusuke Shimizu, Head of Sal... |
| 23.08.2022 | Interim report April – June 2022 | Interim report April – June 2022
Tue, Aug 23, 2022 08:11 CET Report this content
Second quarter in brief
Net sales amounted to 18.7 million SEK (11.8), which means a sales growth of 59 percent.
Operating profit amounted to 4.4 million SEK (... |
| 13.07.2022 | SyntheticMR’s quantitative MRI solution SyMRI NEURO compatible with Philips SmartSpeed to support shorter scan times | SyntheticMR’s quantitative MRI solution SyMRI NEURO compatible with Philips SmartSpeed to support shorter scan times
Wed, Jul 13, 2022 11:00 CET Report this content
SyntheticMR announced today that their product SyMRI NEURO and Philips Smar... |
| 05.07.2022 | Dr. Jeff Miller of Phoenix Children’s Joins SyntheticMR’s Medical Advisory Board | Dr. Jeff Miller of Phoenix Children’s Joins SyntheticMR’s Medical Advisory Board
Tue, Jul 05, 2022 15:00 CET Report this content
SyntheticMR is thrilled to announce the appointment of Dr. Jeff Miller to their Medical Advisory Board.
Dr. Mil... |
| 30.06.2022 | SyntheticMR announces new subsidiary in India | SyntheticMR announces new subsidiary in India
Thu, Jun 30, 2022 10:10 CET Report this content
SyntheticMR announced today that they have established a subsidiary in India. This will be the company’s second subsidiary, following the establis... |
| 30.05.2022 | SyMRI MSK from SyntheticMR is now available on syngo.via Open Apps from Siemens Healthineers | SyMRI MSK from SyntheticMR is now available on syngo.via Open Apps from Siemens Healthineers
Mon, May 30, 2022 10:45 CET Report this content
The SyMRI MSK package supports a fast imaging workflow and enhanced capabilities to view tissue pro... |
| 10.05.2022 | Interim report January – March 2022 | Interim report January – March 2022
Tue, May 10, 2022 08:06 CET Report this content
First quarter in brief
Net sales amounted to 9.9 million SEK (14.7), which represents a decrease in sales of 33 percent.
Operating profit amounted to -3.6 m... |
| 08.04.2022 | SyntheticMR publishes annual report for 2021 | SyntheticMR publishes annual report for 2021
Fri, Apr 08, 2022 08:26 CET Report this content
SyntheticMR AB (publ) hereby announces that the Group´s annual report for 2021 has been published.
The annual report is also available on Synthetic... |
| 08.04.2022 | Notice to attend the annual general meeting of SyntheticMR AB (publ) | Notice to attend the annual general meeting of SyntheticMR AB (publ)
Fri, Apr 08, 2022 08:30 CET Report this content
The shareholders of SyntheticMR AB (publ), corporate Reg. No. 556723-8877, are hereby invited to attend the annual general ... |
| 05.04.2022 | SyntheticMR to create new normative database for quantitative brain values | SyntheticMR to create new normative database for quantitative brain values
Tue, Apr 05, 2022 09:20 CET Report this content
SyntheticMR is collaborating with Mahajan Imaging in New Delhi, India, to gather reference values for the Indian popu... |
| 05.04.2022 | SyntheticMR announces estimated net sales for the first quarter 2022 due to delays in customers' purchasing processes | SyntheticMR announces estimated net sales for the first quarter 2022 due to delays in customers' purchasing processes
Tue, Apr 05, 2022 18:26 CET Report this content
There is a great interest in and demand for SyntheticMR's products in all ... |
